CCP
GILD icon

Clarkston Capital Partners’s Gilead Sciences GILD Stock Holding History

Clarkston Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-2,425
Closed -$202K – 121
2016
Q2 		$202K Sell
2,425
-25
-1% -$2.22K 0.01% 118
2016
Q1 		$225K Sell
2,450
-250
-9% -$22.5K 0.01% 115
2015
Q4 		$273K Buy
2,700
+50
+2% +$5.2K 0.02% 113
2015
Q3 		$260K Hold
2,650
– – 0.02% 122
2015
Q2 		$310K Buy
2,650
+500
+23% +$54.6K 0.03% 120
2015
Q1 		$211K Buy
+2,150
New +$218K 0.02% 130

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clarkston Capital Partners's GILD Position: Q3 2016 in Review

Clarkston Capital Partners sold out of Gilead Sciences (GILD) in Q3 2016, closing a stake of 2,425 shares — an estimated $202K sold.

Clarkston Capital Partners first reported a position in GILD in Q1 2015 and held it in 6 quarters. The position peaked at $310K in Q2 2015. 1,558 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

  • Clarkston Capital Partners reported no remaining Gilead Sciences position as of Q3 2016 after selling out during the quarter.
  • Clarkston Capital Partners sold 2,425 Gilead Sciences shares in Q3 2016, an estimated $202K.
  • Clarkston Capital Partners first reported a position in Gilead Sciences in Q1 2015 and held it in 6 quarters.
  • Clarkston Capital Partners's Gilead Sciences position peaked at $310K in Q2 2015.
  • 1,558 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on Clarkston Capital Partners's 13F filing for Q3 2016, filed 28 Oct 2016.